| Targeting the main protease of SARS‐CoV‐2: from the establishment of high throughput screening to the design of tailored inhibitors J Breidenbach, C Lemke, T Pillaiyar, L Schäkel, G Al Hamwi, M Diett, ... Angewandte Chemie International Edition 60 (18), 10423-10429, 2021 | 111 | 2021 |
| Nucleotide analog ARL67156 as a lead structure for the development of CD39 and dual CD39/CD73 ectonucleotidase inhibitors L Schäkel, CC Schmies, RM Idris, X Luo, SY Lee, V Lopez, S Mirza, ... Frontiers in Pharmacology 11, 1294, 2020 | 30 | 2020 |
| Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39–a promising target for cancer immunotherapy L Schäkel, S Mirza, R Winzer, V Lopez, R Idris, H Al-Hroub, J Pelletier, ... Journal for Immunotherapy of Cancer 10 (8), 2022 | 16 | 2022 |
| Development of a selective and highly sensitive fluorescence assay for nucleoside triphosphate diphosphohydrolase1 (NTPDase1, CD39) SY Lee, X Luo, V Namasivayam, J Geiss, S Mirza, J Pelletier, H Stephan, ... Analyst 143 (22), 5417-5430, 2018 | 13 | 2018 |
| Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes M Nassir, U Arad, SY Lee, S Journo, S Mirza, C Renn, H Zimmermann, ... Purinergic signalling 15, 247-263, 2019 | 10 | 2019 |
| Sulfated polysaccharides from macroalgae are potent dual inhibitors of human ATP-hydrolyzing ectonucleotidases NPP1 and CD39 V Lopez, L Schäkel, HJM Schuh, MS Schmidt, S Mirza, C Renn, J Pelletier, ... Marine drugs 19 (2), 51, 2021 | 9 | 2021 |
| 2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors L Schäkel, S Mirza, M Pietsch, SY Lee, T Keuler, K Sylvester, J Pelletier, ... Archiv der Pharmazie 354 (12), 2100300, 2021 | 6 | 2021 |
| Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno) therapy SY Lee, V Namasivayam, NM Boshta, A Perotti, S Mirza, S Bua, ... RSC Medicinal Chemistry 12 (7), 1187-1206, 2021 | 6 | 2021 |
| Adenine-(methoxy)-ethoxy-P α, α-dithio-triphosphate inhibits pathologic calcium pyrophosphate deposition in osteoarthritic human chondrocytes M Nassir, S Mirza, U Arad, S Lee, M Rafehi, IY Attah, C Renn, ... Organic & Biomolecular Chemistry 17 (46), 9913-9923, 2019 | 6 | 2019 |
| Stereocontrolled access to thioisosteres of nucleoside di-and triphosphates HJ Zhang, M Ociepa, M Nassir, B Zheng, SA Lewicki, V Salmaso, ... Nature Chemistry 16 (2), 249-258, 2024 | 2 | 2024 |
| Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1)–a promising target for the immunotherapy of cancer V Lopez, HJM Schuh, S Mirza, VJ Vaaßen, MS Schmidt, K Sylvester, ... Frontiers in Immunology 14, 1173634, 2023 | 2 | 2023 |
| Practical Stereocontrolled Access to Thioisosteres of Essential Signaling Molecules and Building Blocks for Life: Nucleoside Di-and Triphosphates HJ Zhang, M Ociepa, M Nassir, B Zheng, S Lewicki, V Salmaso, H Babury, ... | 1 | 2022 |
| Die Hauptprotease von SARS‐CoV‐2 als Zielstruktur: Von der Etablierung eines Hochdurchsatz‐Screenings zum Design maßgeschneiderter Inhibitoren J Breidenbach, C Lemke, T Pillaiyar, L Schäkel, G Al Hamwi, M Diett, ... Angewandte Chemie 133 (18), 10515-10521, 2021 | 1 | 2021 |
| Synthesis and structure–activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39 C Bi, L Schäkel, S Mirza, K Sylvester, J Pelletier, SY Lee, T Pillaiyar, ... Bioorganic Chemistry 135, 106460, 2023 | | 2023 |
| Marco Idzko, Medical University of Vienna, Austria NJ Geraghty, OM Vanakker, CE Müller, G Bendas, V Lopez, HJM Schuh, ... | | 2023 |
| RSC Medicinal Chemistry d1md00117e SY Lee, V Namasivayam, NM Boshta, A Perotti, S Mirza, S Bua, ... | | |
